EUVIMEDEUVIMED entdecken
Crossref

Design, Development, Impurity Characterization for Comprehensive Impurity Profiling in Eprosartan Mesylate by a Robust LC-MS/MS-Q-TOF Method: Emphasis on EPR-I, EPR-II, and Regio-Isomers

Vasanth Vasanth Pm, Swetha Sri Remidicherla, Atla Srinivasa Rao

Indian Journal of Pharmaceutical Education and Research · 23.10.2026 · 61 (1) · 331-338

DOI: 10.5530/ijper.20273045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 23.10.2026. Verfasst von Vasanth Vasanth Pm und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pm, V. V., Remidicherla, S. S., & Rao, A. S. (2026). Design, Development, Impurity Characterization for Comprehensive Impurity Profiling in Eprosartan Mesylate by a Robust LC-MS/MS-Q-TOF Method: Emphasis on EPR-I, EPR-II, and Regio-Isomers. Indian Journal of Pharmaceutical Education and Research, 61(1), 331-338. https://doi.org/10.5530/ijper.20273045

Vancouver

Pm VV, Remidicherla SS, Rao AS. Design, Development, Impurity Characterization for Comprehensive Impurity Profiling in Eprosartan Mesylate by a Robust LC-MS/MS-Q-TOF Method: Emphasis on EPR-I, EPR-II, and Regio-Isomers. Indian Journal of Pharmaceutical Education and Research. 2026;61(1):331-338. doi:10.5530/ijper.20273045

BibTeX
@article{Pm2026,
  author = {Pm, Vasanth Vasanth and Remidicherla, Swetha Sri and Rao, Atla Srinivasa},
  title = {Design, Development, Impurity Characterization for Comprehensive Impurity Profiling in Eprosartan Mesylate by a Robust LC-MS/MS-Q-TOF Method: Emphasis on EPR-I, EPR-II, and Regio-Isomers},
  journal = {Indian Journal of Pharmaceutical Education and Research},
  year = {2026},
  volume = {61},
  number = {1},
  pages = {331--338},
  doi = {10.5530/ijper.20273045}
}
Kostenlos starten →